Sort
16,300 grants matching “fatty liver disease”
Elucidating the role of the FXR-PTEN-PI3K-AKT-mTOR axis in liver progenitor cell-driven liver regeneration
$502,844Donghun Shin · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DK
Elucidating the role of the FXR-PTEN-PI3K-AKT-mTOR axis in liver progenitor cell-driven liver regeneration
$502,842Donghun Shin · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C
$502,831Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Dietary Effects on Imaging and Fluid-based Biomarkers of the Adipose-Brain Axis in Alzheimers Disease
$502,823Tina E Brinkley · Wake Forest University Health Sciences · R01 · FY2023 · AG
Microbial Metabolite Mimics, PXR and Colitis-Induced Colorectal Cancer
$502,449Sridhar Mani · Albert Einstein College Of Medicine · R01 · FY2020 · CA
Transcriptional and metabolic regulation of Treg cell specification for the control of allergic airway disease
$502,332Kai Yang · Indiana University Indianapolis · R01 · FY2025 · AI
Transcriptional and metabolic regulation of Treg cell specification for the control of allergic airway disease
$502,332Kai Yang · Indiana University Indianapolis · R01 · FY2022 · AI
gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention
$502,311Fung-Lung Chung · Georgetown University · U01 · FY2019 · CA
Multiscale Analysis of Inter-Clock Communication
$502,288John B Hogenesch · University Of Pennsylvania · R01 · FY2011 · HL
PCSK9, Lipoprotein receptors, and Atherosclerosis
$502,190Sergio Fazio · Vanderbilt University · R01 · FY2012 · HL
Scavenger Receptors: Ligand Binding and Pathophysiology
$502,144Monty Krieger · Massachusetts Institute Of Technology · R01 · FY2010 · HL
Identification of metabolic regulators of glycerolipid synthesis and storage
$502,049Kivanc Birsoy · Rockefeller University · R01 · FY2020 · DK
Metabolic regulation of stem cell niche development and function
$502,002Cheng-Kui Qu · Emory University · R01 · FY2023 · HL
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
$501,946Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2023 · CA
Role of STING in Cholestatic Liver Injury
$501,915Shannon Stroud Glaser · Texas A&M University Health Science Ctr · R01 · FY2023 · DK
The Role of Microbiome Modulation in Morphine-Induced Exacerbation of Pancreatitis
$501,885Sabita Roy · University Of Miami School Of Medicine · R01 · FY2020 · DK
The Role of Microbiome Modulation in Morphine-Induced Exacerbation of Pancreatitis
$501,885Ashok K Saluja · University Of Miami School Of Medicine · R01 · FY2019 · DK
The Role of Microbiome Modulation in Morphine-Induced Exacerbation of Pancreatitis
$501,885Sabita Roy · University Of Miami School Of Medicine · R01 · FY2021 · DK
RAGE, DIAPH1 and IRF7 and Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Disease
$501,779Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2022 · HL
RAGE, DIAPH1 and IRF7 and Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Disease
$501,779Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2023 · HL
Brain endoplasmic reticulum stress in non-alcoholic fatty liver disease
$501,750Colin Neal Young · George Washington University · R01 · FY2019 · DK
Non Alcoholic Steatohepatitis Clinical Research Network
$501,622Arthur J McCullough · Cleveland Clinic Lerner Com-Cwru · U01 · FY2016 · DK
Identifying genes required for digestive physiology and lipid metabolism
$501,614Steven A Farber · Carnegie Institution Of Washington, D.C. · R01 · FY2016 · DK
Biopsychosocial Determinants of Adolescent Obesity-Cardiovascular Risk
$501,601Sheila Gahagan · University Of California, San Diego · R01 · FY2015 · HL
Mechanisms regulating the atherogenic activities of serum amyloid A
$501,577Lisa R Tannock · University Of Kentucky · R01 · FY2022 · HL